ArticleMolecular cancer therapeutics2014

The phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells.

Elgilda Musi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.